Cardiac doses of radical radiotherapy impact survival in NSCLC: a real-world analysis
Addressing the issues faced in the ProtecT trial for patients with localized prostate cancer
10-year follow-up: the most effective treatment to ProtecT patients with localized prostate cancer?
PROs of the ProtecT trial: is using data provided by patients a good tool for counselling?
Case-based debate: is there evidence for local treatment in oligometastatic prostate cancer?